¼¼°èÀÇ ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ ½ÃÀå
Polymerase Chain Reaction
»óǰÄÚµå : 1544024
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 182 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,260,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,780,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ ½ÃÀåÀº 2030³â±îÁö 131¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2023³â¿¡ 93¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ ½ÃÀåÀº 2023-2030³â CAGR 5.0%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 131¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ PCR ±â±â´Â CAGR 4.9%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 34¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. PCR ½Ã¾à & ¼Ò¸ðǰ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 5.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 25¾ï ´Þ·¯·Î ÃßÁ¤¡¤¿¹Ãø, Áß±¹Àº CAGR 7.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ ½ÃÀåÀº 2023³â¿¡ 25¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 29¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³â CAGRÀº 7.6%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.7%¿Í 4.4%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ : Çö´ë ºÐÀÚ»ý¹°ÇÐÀÇ Ãʼ®

ÁßÇÕÈ¿¼Ò ¿¬¼â ¹ÝÀÀ(PCR)Àº ƯÁ¤ DNA ¼­¿­À» ÁõÆøÇÒ ¼öÀÖ´Â ºÐÀÚ »ý¹°ÇÐÀÇ Çõ½ÅÀûÀÎ ±â¼ú·Î 1983³âKary Mullis¿¡ ÀÇÇØ °³¹ßµÈ PCRÀº ¿¬±¸ÀÚµéÀÌ ºñ±³Àû ªÀº ½Ã°£¿¡ ƯÁ¤ DNA Á¶°¢À» ¼ö¹é¸¸ °³ÀÇ »çº»À» ¸¸µé ¼öÀÖ°Ô ÇØÁÖ¾ú½À´Ï´Ù. ÀÌ °úÁ¤Àº ¹Ýº¹ÀûÀÎ °¡¿­ ¹× ³Ã°¢ »çÀÌŬÀ» ÅëÇØ DNA ÀÌÁß ³ª¼±ÀÇ º¯¼º, ÇÁ¶óÀ̸Ӹ¦ Ç¥Àû ¼­¿­·Î ¾î´Ò¸µÇϰí DNA ÁßÇÕÈ¿¼Ò¿¡ ÀÇÇÑ ÇÁ¶óÀ̸ÓÀÇ ¿¬ÀåÀ» ÃËÁøÇÏ´Â °úÁ¤À» °ÅĨ´Ï´Ù. ÀϹÝÀûÀ¸·Î ¹ÝÀÀ È¥ÇÕ¹°¿¡´Â DNA ÁÖÇü, µÎ À¯ÇüÀÇ ÇÁ¶óÀ̸Ó, À¯¸® ´ºÅ¬·¹¿ÀƼµå, ¿ÏÃæ¾×, º¯¼º¿¡ ÇÊ¿äÇÑ °í¿Â¿¡ °ßµô ¼ö ÀÖ´Â Taq ÁßÇÕÈ¿¼Ò¿Í °°Àº ³»¿­¼º DNA ÁßÇÕÈ¿¼Ò°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ÀÌ ÁÖ±âÀûÀÎ °úÁ¤À» ÅëÇØ Ç¥Àû DNA ¿µ¿ªÀÌ ±âÇϱ޼öÀûÀ¸·Î ÁõÆøµÇ¾î PCRÀº À¯ÀüÀÚ ¿¬±¸, Áø´Ü ¹× ¹ýÀÇÇп¡¼­ ÇʼöÀûÀÎ ÅøÀÌ µË´Ï´Ù.

PCRÀº ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ¾î¶»°Ô Ȱ¿ëµÇ°í Àִ°¡?

PCRÀº DNA¸¦ ºü¸£°í Á¤È®ÇÏ°Ô ÁõÆøÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ ´Ù¾çÇÑ °úÇÐ ¹× ÀÇ·á ºÐ¾ß¿¡¼­ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á Áø´Ü¿¡¼­ PCRÀº ¹ÚÅ׸®¾Æ³ª ¹ÙÀÌ·¯½º¿Í °°Àº º´¿øÃ¼¸¦ °ËÃâÇϰí Á¤·®È­ÇÏ¿© HIV, °£¿°, COVID-19¿Í °°Àº °¨¿°¼º ÁúȯÀ» ½Äº°ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. À¯ÀüÇÐ °Ë»çµµ PCRÀÇ ÇýÅÃÀ» ¹Þ¾Æ À¯Àü¼º Áúȯ°ú °ü·ÃµÈ µ¹¿¬º¯À̸¦ ½Äº°Çϰí Á¶±â Áø´Ü ¹× °³º°È­µÈ Ä¡·á °èȹÀ» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹ýÀÇÇÐ ºÐ¾ß¿¡¼­ PCRÀº ¹üÁË ÇöÀå¿¡¼­ äÃëÇÑ ¹Ì¼¼ÇÑ DNA »ùÇÃÀ» ºÐ¼®ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇϸç, ¿ëÀÇÀÚ¿Í ¹üÁË ÇàÀ§¸¦ ¿¬°áÇÏ´Â Áõ°Å¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ PCRÀº »ý¸í°øÇÐ ¹× Á¦¾à »ê¾÷¿¡¼­ º¹Á¦, À¯ÀüÀÚ ¹ßÇö ºÐ¼®, À¯ÀüÀÚ º¯Çü »ý¹°Ã¼ Á¦ÀÛ µî¿¡ »ç¿ëµÇ´Â µî »ý¸í°øÇÐ ¹× Á¦¾à »ê¾÷¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, PCRÀÇ ´Ù¾ç¼º°ú Á¤È®¼ºÀº À¯ÀüÇп¡ ´ëÇÑ ÀÌÇØ¸¦ ³ôÀÌ°í °øÁß º¸°Ç°ú ¾ÈÀüÀ» °³¼±ÇÏ´Â µ¥ ÇʼöÀûÀÎ ±â¼úÀÔ´Ï´Ù. ÇʼöÀûÀÎ ±â¼úÀÔ´Ï´Ù.

PCR ±â¼ú ¹× ÀÀ¿ëÀÇ ÇöÀç µ¿ÇâÀº?

ºÐÀÚ»ý¹°ÇÐÀÇ ¹ßÀü°ú ½Å¼ÓÇϰí Á¤È®ÇÑ À¯ÀüÀÚ ºÐ¼®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î PCRÀÇ ±â¼ú°ú ÀÀ¿ëÀº Áö¼ÓÀûÀ¸·Î ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. Áß¿äÇÑ µ¿Çâ Áß Çϳª´Â ½Ç½Ã°£ PCR·Îµµ ¾Ë·ÁÁø Á¤·®Àû PCR(qPCR)ÀÇ °³¹ß·Î, ½Ç½Ã°£À¸·Î DNA ¶Ç´Â RNA¸¦ Á¤·®È­ÇÒ ¼ö ÀÖÀ¸¸ç, À¯ÀüÀÚ ¹ßÇö ¹× ¹ÙÀÌ·¯½º ¾ç¿¡ ´ëÇÑ ±ÍÁßÇÑ ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù. µðÁöÅÐ PCR(dPCR)Àº ¶Ç ´Ù¸¥ Çõ½ÅÀ¸·Î, »ùÇÃÀ» ¼öõ °³ÀÇ °³º° ¹ÝÀÀÀ¸·Î ºÐÇÒÇÏ¿© ´õ ³ôÀº Á¤È®µµ¿Í ¹Î°¨µµ¸¦ Á¦°øÇÏ¿© ÇÙ»êÀÇ Àý´ëÀûÀÎ Á¤·®À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¸¶ÀÌÅ©·ÎÇ÷çÀ̵åÀÇ ¹ßÀüÀ¸·Î ÈÞ´ë¿ë PCR Àåºñ°¡ °³¹ßµÇ¾î ÀÚ¿øÀÌ Á¦ÇÑµÈ È¯°æÀ̳ª ÇöÀå¿¡¼­ À¯ÀüÀÚ °Ë»ç¸¦ ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ÇÑ ¹øÀÇ ¹ÝÀÀÀ¸·Î ¿©·¯ Ç¥ÀûÀ» ÁõÆøÇÒ ¼ö ÀÖ´Â ¸ÖƼÇ÷º½º PCRÀº ½Ã°£°ú ½Ã¾àÀÇ ¼Òºñ¸¦ ÁÙ¿© À¯ÀüÀÚ °Ë»çÀÇ È¿À²¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â PCRÀÇ Á¤È®¼º, È¿À²¼º, Á¢±Ù¼ºÀ» Çâ»ó½Ã۱â À§ÇÑ Áö¼ÓÀûÀÎ ³ë·ÂÀ» ¹Ý¿µÇϰí ÀÖÀ¸¸ç, ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ÀÇ Àû¿ë °¡´É¼ºÀ» ³ÐÇô°¡°í ÀÖ½À´Ï´Ù.

PCR ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

PCR ½ÃÀåÀÇ ¼ºÀåÀº °í±Þ À¯ÀüÀÚ ºÐ¼® ¹× Áø´Ü Åø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ ¹Ý¿µÇÏ´Â ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ºÐ¾ßÀÇ È®´ë, ƯÈ÷ °¨¿°¼º ÁúȯÀÇ È®»ê°ú Á¶±â Áø´ÜÀÇ Çʿ伺 Áõ°¡´Â PCR ±â¼úÀÇ Áß¿äÇÑ ÃËÁøÁ¦À̸ç, qPCR ¹× dPCRÀÇ °³¹ß°ú °°Àº ±â¼ú ¹ßÀüÀº PCRÀÇ ´É·Â°ú Á¤È®¼ºÀ» Çâ»ó½ÃÄÑ ´Ù¾çÇÑ ¿ëµµ¿¡¼­ äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í Ä¡·á °áÁ¤À» À§ÇÑ Á¤È®ÇÑ À¯ÀüÀÚ °Ë»ç¿¡ ´ëÇÑ Çʿ伺ÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀå¿¡ ÈûÀ» ½Ç¾îÁÖ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ »ý¸í°øÇÐ ¹× Á¦¾à »ê¾÷ÀÇ R&D Ȱµ¿ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½Å¾à °³¹ß ¹× À¯Àü°øÇÐ ºÐ¾ß¿¡¼­ PCR¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹ýÀÇÇÐ ¹× ȯ°æ ¸ð´ÏÅ͸µ¿¡¼­ PCRÀÇ »ç¿ë Áõ°¡´Â ½ÃÀå È®´ë¸¦ ´õ¿í Áö¿øÇϰí ÀÖÀ¸¸ç, PCR ±â¼úÀÇ Çõ½Å°ú °³¼±À» À§ÇÑ Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß ³ë·ÂÀº PCR ½ÃÀåÀÇ °­·ÂÇÑ ¼ºÀåÀ» º¸ÀåÇÏ°í ºÐÀÚ »ý¹°ÇÐÀÇ ¹ßÀü°ú °øÁß º¸°Ç °á°ú °³¼±¿¡ ÀÖÀ¸¸ç, PCRÀÇ Áß¿äÇÑ ¿ªÇÒÀ» °­Á¶Çϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÃÑ 17°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Polymerase Chain Reaction Market to Reach US$13.1 Billion by 2030

The global market for Polymerase Chain Reaction estimated at US$9.3 Billion in the year 2023, is expected to reach US$13.1 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. PCR Instruments, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the PCR Reagents & Consumables segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 7.6% CAGR

The Polymerase Chain Reaction market in the U.S. is estimated at US$2.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 7.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Polymerase Chain Reaction Market - Key Trends and Drivers Summarized

Polymerase Chain Reaction: A Cornerstone of Modern Molecular Biology

Polymerase Chain Reaction (PCR) is a revolutionary technique in molecular biology that allows for the amplification of specific DNA sequences. Developed by Kary Mullis in 1983, PCR enables researchers to produce millions of copies of a particular DNA segment in a relatively short amount of time. The process involves repeated cycles of heating and cooling, which facilitate the denaturation of the DNA double helix, the annealing of primers to target sequences, and the extension of these primers by a DNA polymerase enzyme. Typically, the reaction mixture contains the DNA template, two primers, free nucleotides, a buffer solution, and the thermostable DNA polymerase, such as Taq polymerase, which can withstand the high temperatures required for denaturation. This cyclical process results in the exponential amplification of the target DNA region, making PCR an indispensable tool in genetic research, diagnostics, and forensic science.

How Is PCR Utilized Across Different Fields?

PCR is utilized extensively across various scientific and medical fields due to its ability to rapidly and accurately amplify DNA. In medical diagnostics, PCR is employed to detect and quantify pathogens, such as bacteria and viruses, enabling the identification of infections like HIV, hepatitis, and COVID-19. Genetic testing also benefits from PCR, as it can identify mutations associated with hereditary diseases, facilitating early diagnosis and personalized treatment plans. In the field of forensic science, PCR is crucial for analyzing minute DNA samples from crime scenes, providing evidence that can link suspects to criminal activities. Additionally, PCR plays a significant role in research and development within biotechnology and pharmaceutical industries, where it is used for cloning, gene expression analysis, and the creation of genetically modified organisms. The versatility and precision of PCR make it an essential technique for advancing our understanding of genetics and improving public health and safety.

What Are the Current Trends in PCR Technology and Applications?

The technology and applications of PCR are continuously evolving, driven by advancements in molecular biology and the increasing demand for rapid and accurate genetic analysis. One significant trend is the development of quantitative PCR (qPCR), also known as real-time PCR, which allows for the quantification of DNA or RNA in real-time, providing valuable insights into gene expression and viral load. Digital PCR (dPCR) is another innovation, offering higher precision and sensitivity by partitioning the sample into thousands of individual reactions, enabling absolute quantification of nucleic acids. Advances in microfluidics are leading to the creation of portable PCR devices, making it possible to conduct genetic testing in resource-limited settings or in the field. Additionally, multiplex PCR, which can amplify multiple targets in a single reaction, is enhancing the efficiency of genetic testing by reducing time and reagent consumption. These trends reflect the ongoing efforts to improve the accuracy, efficiency, and accessibility of PCR, expanding its potential applications in diverse fields.

What Factors Are Driving the Growth in the PCR Market?

The growth in the PCR market is driven by several factors, reflecting the increasing demand for advanced genetic analysis and diagnostic tools. The expansion of the healthcare sector, particularly the rising prevalence of infectious diseases and the need for early diagnosis, is a significant driver for PCR technology. Technological advancements, such as the development of qPCR and dPCR, are enhancing the capabilities and accuracy of PCR, encouraging its adoption in various applications. The growing focus on personalized medicine and the need for precise genetic testing to guide treatment decisions are also propelling market growth. Additionally, the rise in research and development activities within biotechnology and pharmaceutical industries is boosting the demand for PCR in drug discovery and genetic engineering. The increasing use of PCR in forensic science and environmental monitoring further supports market expansion. Continuous research and development efforts to innovate and improve PCR technologies ensure robust growth in the PCR market, underscoring its essential role in advancing molecular biology and improving public health outcomes.

Select Competitors (Total 17 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â